Zobrazeno 1 - 2
of 2
pro vyhledávání: '"on, behalf of Saitama Breast Cancer Clinical Study Group (SBCCSG)"'
Autor:
Yuji, Hayashi, Hiroyuki, Takei, Tsuyoshi, Saito, Toshihiro, Kai, Kenichi, Inoue, Masafumi, Kurosumi, Jun, Ninomiya, on, behalf of Saitama Breast Cancer Clinical Study Group (SBCCSG), Hayashi, Yuji, Takei, Hiroyuki, Saito, Tsuyoshi, Kai, Toshihiro, Inoue, Kenichi, Kurosumi, Masafumi, Ninomiya, Jun, behalf of Saitama Breast Cancer Clinical Study Group (SBCCSG), on
Publikováno v:
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi. 88(4)
BACKGROUND Neoadjuvant endocrine therapy is not the standard of care for breast cancer, primarily because the optimal treatment duration remains unclear. This phase 2 prospective multicenter study analyzed time to progression, time to maximal respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4515aa0b564883263d2a412bdaf0ae6c
https://pubmed.ncbi.nlm.nih.gov/33250473
https://pubmed.ncbi.nlm.nih.gov/33250473
Autor:
Yuji Hayashi1,2 takei-hiroyuki@nms.ac.jp, Hiroyuki Takei2,3, Tsuyoshi Saito1, Toshihiro Kai4, Kenichi Inoue5, Masafumi Kurosumi6,7, Jun Ninomiya2,8
Publikováno v:
Journal of Nippon Medical School. 2021, Vol. 88 Issue 4, p354-360. 7p.